{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:41:59Z","timestamp":1789839719183,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.diabres.2024.111965","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:30:07Z","timestamp":1734719407000},"page":"111965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Health disparities in diabetes treatment: The challenge of G6PD deficiency"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-8896","authenticated-orcid":false,"given":"Ariel","family":"Israel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itamar","family":"Raz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-6402","authenticated-orcid":false,"given":"Avivit","family":"Golan-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matitiahu","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Vinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Merzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111965_b0005","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJM198910193211603","article-title":"Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes","volume":"321","author":"Cowie","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/diacare.22.3.403","article-title":"Racial and ethnic differences in glycemic control of adults with type 2 diabetes","volume":"22","author":"Harris","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111965_b0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ijerph17030950","article-title":"Racial\/ethnic differences in glycemic control in older adults with type 2 diabetes: United States 2003\u20132014","volume":"17","author":"Smalls","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.diabres.2024.111965_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2024.111965_b0025","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.7326\/0003-4819-65-6-1329","article-title":"Clinical implications of glucose-6-phosphate dehydrogenase deficiency","volume":"65","author":"Motulsky","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2024.111965_b0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/dmt.11.48","article-title":"Addressing diabetes racial and ethnic disparities: lessons learned from quality improvement collaboratives","volume":"1","author":"Wilkes","year":"2011","journal-title":"Diabetes Manag (Lond)"},{"key":"10.1016\/j.diabres.2024.111965_b0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-8587(23)00129-8","article-title":"Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward","volume":"11","author":"Hassan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2024.111965_b0040","article-title":"Preliminary investigation into the prevalence of G6PD deficiency in a pediatric african american population using a near-patient diagnostic platform","volume":"13","author":"Leung-Pineda","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.diabres.2024.111965_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7205\/MILMED.171.9.905","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel","volume":"171","author":"Chinevere","year":"2006","journal-title":"Mil Med"},{"key":"10.1016\/j.diabres.2024.111965_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2024.111965_b0055","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41598-024-57958-3","article-title":"Quantifying the effect of glucose 6-phosphate dehydrogenase deficiency on glycated hemoglobin values in children and adolescents with type 1 diabetes","volume":"14","author":"Ripoli","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2024.111965_b0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMc2406156","article-title":"Type 2 diabetes in patients with G6PD deficiency","volume":"391","author":"Israel","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12933-021-01281-y","article-title":"From glucose lowering agents to disease\/diabetes modifying drugs: a \u201cSIMPLE\u201d approach for the treatment of type 2 diabetes","volume":"20","author":"Mosenzon","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2024.111965_b0070","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0075","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111965_b0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2024.111965_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100477","article-title":"Call to action: understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists","volume":"13","author":"Khedagi","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.diabres.2024.111965_b0100","article-title":"Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study","volume":"375","author":"Israel","year":"2021","journal-title":"The BMJ"},{"key":"10.1016\/j.diabres.2024.111965_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad348","article-title":"Glucose-6-phosphate dehydrogenase deficiency and coronavirus disease 2019","author":"Israel","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2024.111965_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2024.111965_b0115","first-page":"260","article-title":"Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre","volume":"21","author":"Shenkutie","year":"2022","journal-title":"Eastern Ethiopia Malar J"},{"key":"10.1016\/j.diabres.2024.111965_b0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2024.111965_b0125","first-page":"191","author":"Hastie","year":"2009","journal-title":"Kernel Smoothing Methods"},{"key":"10.1016\/j.diabres.2024.111965_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gde.2018.02.008","article-title":"Genetics of HbA1c: a case study in clinical translation","volume":"50","author":"Leong","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.diabres.2024.111965_b0135","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/s41591-024-03089-1","article-title":"Adaptive selection at G6PD and disparities in diabetes complications","volume":"30","author":"Breeyear","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2024.111965_b0140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41588-024-01881-w","article-title":"G6PD deficiency and diabetes complications","volume":"56","author":"Vogan","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2024.111965_b0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.diabres.2024.111965_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12902-021-00911-6","article-title":"Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation","volume":"21","author":"Karadsheh","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabres.2024.111965_b0155","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.3390\/ijms23137425","article-title":"G6PD deficiency is crucial for insulin signaling activation in skeletal muscle","volume":"23","author":"Jiang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2024.111965_b0160","first-page":"1055","article-title":"The redox role of G6PD in cell growth","volume":"8","author":"Yang","year":"2019","journal-title":"Cell Death, and Cancer Cells"},{"key":"10.1016\/j.diabres.2024.111965_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1076\/ceyr.25.1.9.9960","article-title":"Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients","volume":"25","author":"Donma","year":"2002","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.diabres.2024.111965_b0170","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.7150\/ijms.6776","article-title":"Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a sardinian population","volume":"10","author":"Pinna","year":"2013","journal-title":"Italy Int J Med Sci"},{"key":"10.1016\/j.diabres.2024.111965_b0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2019.01.027","article-title":"Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: a propensity score-matched study","volume":"282","author":"Pes","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2024.111965_b0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/21623945.2017.1288321","article-title":"The role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in obesity","volume":"6","author":"Park","year":"2017","journal-title":"Adipocyte"},{"key":"10.1016\/j.diabres.2024.111965_b0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000056744.26901.BA","article-title":"Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide","volume":"23","author":"Leopold","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2024.111965_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1232560","article-title":"Glucose-6-phosphate dehydrogenase deficiency and long-term risk of immune-related disorders","volume":"14","author":"Israel","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2024.111965_b0195","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00003246-200104000-00005","article-title":"Increased incidence of sepsis and altered monocyte functions in severely injured type A\u2212 glucose-6-phosphate dehydrogenase-deficient African American trauma patients","volume":"29","author":"Spolarics","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diabres.2024.111965_b0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/antibiotics12030494","article-title":"Infections in glucose-6-phosphate dehydrogenase G6PD-deficient patients; predictors for infection-related mortalities and treatment outcomes","volume":"12","author":"Alrahmany","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.diabres.2024.111965_b0205","doi-asserted-by":"crossref","unstructured":"Xie L, Shao X, Yu Y, Gong W, Sun F, Wang M, et al. Anemia is a risk factor for rapid eGFR decline in type 2 diabetes. Front Endocrinol (Lausanne) 2023;14. 10.3389\/fendo.2023.1052227.","DOI":"10.3389\/fendo.2023.1052227"},{"key":"10.1016\/j.diabres.2024.111965_b0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/antiox13010016","article-title":"Anti-inflammation and anti-oxidation: the key to unlocking the cardiovascular potential of SGLT2 inhibitors and GLP1 receptor agonists","volume":"13","author":"Myasoedova","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.diabres.2024.111965_b0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MNH.0000000000000935","article-title":"Novel pharmacological interventions for diabetic kidney disease","volume":"33","author":"Tan","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.diabres.2024.111965_b0220","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.dsx.2019.01.031","article-title":"Association of fasting glucagon-like peptide-1 with oxidative stress and subclinical atherosclerosis in type 2 diabetes","volume":"13","author":"Alharby","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.diabres.2024.111965_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102849","article-title":"Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes","volume":"66","author":"Luna-Marco","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.diabres.2024.111965_b0230","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajhg.2019.08.010","article-title":"Impact of rare and common genetic variants on diabetes diagnosis by hemoglobin A1c in Multi-Ancestry cohorts: the Trans-Omics for precision medicine program","volume":"105","author":"Sarnowski","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.diabres.2024.111965_b0235","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0946","article-title":"Use of SGLT2 inhibitors vs GLP-1 RAs and anemia in patients with diabetes and CKD","volume":"7","author":"Hu","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:56:11Z","timestamp":1740102971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724008751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"alternative-id":["S0168822724008751"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111965","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health disparities in diabetes treatment: The challenge of G6PD deficiency","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111965"}}